Bio-Rad Laboratories
Presence
Bio-Rad Laboratories is one of the...
Bio-Rad Laboratories is a company listed under the stock ticker BIO (US).
Executives
View the org chart displaying its 24 main executives
Most searched biographies at Bio-Rad Laboratories
- Norman Schwartz, Chairman of the Board, President and Chief Execut...
- Melinda Litherland, Director
- Arnold Pinkston, Director
Popular executive movements at Bio-Rad Laboratories
- Simon May, Executive Vice President and President, Life Science Group, will leave the company on May 1, 2024 (posted on April 28 2024).
- Jim Barry who is Senior Vice President and General Manager, Clinical Diagnostics, will be promoted to Executive Vice President and President of Life Science Group on May 1, 2024 (posted on April 28 2024).
- Andrew Last, Executive Vice President and Chief Operating Officer, will retire on Sep. 1, 2024 (posted on April 12 2024).
Click here to view some more movements at Bio-Rad Laboratories
Create your alert
to follow the executive moves at Bio-Rad Laboratories.
Medical Equipment
Bio-Rad Laboratories has 979 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by Bio-Rad Laboratories
- Bio-Rad Launches Three StarBright Red Dyes and Expands Range of Antibody Markers Conjugated to StarBright Violet Dyes to Enhance Immunology Research
- Bio-Rad Announces Collaboration Agreement with Oncocyte to Commercialize Transplant Monitoring with Droplet Digital PCR
- Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
- Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
- Bio-Rad Launches Celselect Slides Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
- Bio-Rad Reports Second-Quarter 2023 Financial Results
- Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
- Bio-Rad Announces New Share Repurchase Program
- Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
- View more press releases Close
Social media about Bio-Rad Laboratories
- Bio-Rad Laboratories on Wikipedia, Google News & Yahoo Finance
- Bio-Rad Laboratories on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Norman Schwartz 
Call Bio-Rad Laboratories at +1 510...
